Hexosamine induction of oxidative stress, hypertrophy and laminin expression in renal mesangial cells: Effect of the anti-oxidant α-lipoic acid

Cell Biochemistry and Function

Volumn 25, Issue 5, 2007, Pages 537-550

  Singh, Lalit P ^a   Cheng, Davis W ^a   Kowluru, Renu ^a   Levi, Edi ^b   Jiang, Yan ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

lipoic acid; Cell death; Extracellular matrix; Hexosamine; Mesangial cell; Oxidative stress

Indexed keywords

AZASERINE; CYCLIN D1; GLUCOSE; HEXOSAMINE; LAMININ; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; THIOCTIC ACID;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CONTROLLED STUDY; DIABETES MELLITUS; FLUORESCENCE ACTIVATED CELL SORTING; HYPERTROPHY; KIDNEY CORTEX; MESANGIUM CELL; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE; CELL SURVIVAL; CYCLIN D1; DIABETES MELLITUS, EXPERIMENTAL; DNA; GLUCOSAMINE; GLUCOSE; HYPERTROPHY; LAMININ; MESANGIAL CELLS; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RNA; THIOCTIC ACID;

RATTUS;

EID: 34548802931     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1358     Document Type: Article

References (48)

1. Mauer SM, Steffes MW, Brown DM. The kidney in diabetes. Am J Med 1996: 70: 603-612.
2. Osterby R, Gundersen HG, Horlyck A, Nyberg G, Westberg G. Diabetic glomerulopathy: structural characteristics of the early and advanced stages. Diabetes 1983; 32: 79-82.
3. Dulop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 2000; 77: S3-S12.
4. Thomas MC, Forbes JM, Cooper ME. Advanced glycation end products and diabetic nephropathy. Am J Ther 2005; 12: 562-572.
5. Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995; 44: 1139-1146.
6. Flyvbjerg A. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes. Kidney In. 1997; 52: S12-S19.
7. Cummings EA, Sochett EB, Dekker MG, Lawson ML, Daneman D. Contribution of growth factors and IGF-1 to early diabetic nephropathy in type 1 diabetes. Diabetes 1998; 47: 1341-1346.
8. Herbert LF, Jr., Zhou J, Daniel MC, Crook ED, et al. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 1996; 98: 930-936.
9. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED. High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 1998; 101: 160-169.
10. Rossetti L. Hexosamines and nutrient sensing. Endocrinology 2000; 141: 1922-1925.
11. Singh LP, Andy JC, Anyamale V, Greene K, Alexander M, Crook ED. The hexosamine biosynthesis pathway-mediated fibronectin synthesis in mesangial cells is associated with increases in CREB phosphorylation and nuclear CRE binding. The involvement of protein kinase A and C. Diabetes 2001; 50: 2355-2362.
12. Andreozzi F, D'Alessandris C, Federici M, et al. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Art/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic β-cells. Endocrinology 2004; 145: 2845-2857.
13. Buse MA. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 2005; 290: E1-E8.
14. Comer F-I, Hart GW. O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate. J Biol Chem 2000; 22: 29179-29182.
15. Du XL, Edelstein D, Rossetti L, et al. Hyperglycemia induced mitochondrial superoxide production activates the hexosamine pathway and induces plasminogen inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 2000; 97: 12222-12226.
16. Yang X, Su K, Roos MD, Chang Q, Paterson AJ, Kudlow JE. O-linkage of N-acetylglucosamine to Spl activation domain inhibits its transcriptional capacity. Proc Natl Acad Sci USA 2001; 98: 6611-6616.
17. Jiang Y, Cheng DW, Levi E, Singh LP. IGF-1 increases laminin, cyclin Dl, and p21Cip1 expression in glomerular mesangial cells: an investigation of the intracellular signaling pathway and cell-cycle progression. J Cell Biochem 2006; 98: 208-220.
18. Miner JH. Developmental biology of glomerular basement membrane components. Curr Opin Nephrol Hypertens 1998; 7: 13-19.
19. Kortesmaa J, Yurchenco P, Tryggvason K. Recombinant laminin-8 (α4β1γ1). Production, purification, and interactions with integrins. J Biol Chem 2000; 275: 14853-14859.
20. Hansen K, Abrass CK. Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF-induced mesangial cell migration. Kidney Int 2003; 64: 110-111.
21. Feliers D, Meredith AF, Riley DJ. Activation of cyclin D1-cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy. Diabetes 2002; 51: 3290-3299.
22. Awazu M, Omori S, Ishikura K, Hida M, Fujita H. The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy. J Am Soc Nephrol 2003; 14: 819-822.
23. Weiss RH. p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 2003; 4: 425-429.
24. Brownlee M. The pathobiology of diabetic complications. A unifying mechanism. Diabetes 2005; 54: 1615-1625.
25. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen-species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 2003; 14: S241-S245.
26. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE. Nox4 NADP(H) oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 2005; 280: 39616-39626.
27. Melhem MF, Craven PA, Derubertis FR. Effects of diatary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 2001; 12: 124-133.
28. Kwan J, Wang H, Munk S, Xia L, Goldberg HJ, Whiteside CI. In high glucose protein kinase C-zeta activation is required for mesangial cell generation of reactive oxygen species. Kidney Int 2005; 68: 2526-2541.
29. Xu Y, Osborne BW, Stanton RC. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Renal Physiol 2005; 289: F1040-F1047.
30. Singh LP, Crook ED. Hexosamine regulation of glucose-mediated laminin synthesis in mesangial cells involves protein kinase A and C. Am J Physiol Renal Physiol 2000; 279: F646-F654.
31. Singh LP, Gennerette D, Simmons S, Crook ED. Glucose-induced insulin resistance of phosphatidylinositol 3′OH kinase and AKT/PKB is mediated by the hexosamine biosynthetic pathway. J Diab Compl 2001; 15: 88-96.
32. Singh LP, Green K, Alexander M, Bassly S, Crook ED. Hexosamines and TGF-betal use similar signaling pathways to mediate matrix protein synthesis in mesangial cells. Am J Physiol Renal Physiol 2004; 286: F409-F416.
33. Jiang Y, Cheng DW, Crook ED, Singh LP. Transforming growth factor-betal regulation of laminin gammal and fibronectin expression and survival of mouse mesangial cells. Mol Cell Biochem 2005; 278: 165-175.
34. Kowluru A, Odenbach D. Role of interleukin-1β in the development of retinopathy in rats: effect of antioxidants. Invest Ophthalmol Vis Sci 2004; 45: 4161-4166.
35. Daniels MC, McClain DA, Crook ED. Transcriptional regulation of TGF-β1 by glucose: investigation into the role of the hexosamine biosynthesis pathway. Am J Med Sci 2000; 319: 138-142.
36. Goldberg HJ, Scholey J, Fantus IG. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes 2000; 49: 863-871.
37. Kobayashi T, Uehara S, Ikeda T, Itadani H, Kotani H. Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kidney Int 2003; 64: 1632-1642.
38. Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 2004; 279: 30369-30374.
39. Lee EA, Seo JY, Jiang Z, et al. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Kidney Int 2005; 67: 1762-1771.
40. Kowluru RA, Kennedy A. Therapeutic potential of antioxidants and diabetic retinopathy. Expert Opin Investig Drugs 2001; 10: 1665-1676.
41. Da Ros R, Assaloni R, Ceriello A. The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance. Diabet Med 2004; 21: 1249-1252.
42. Trachman H. Vitamin E prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Microvas Res 1994; 47: 232-239.
43. Fan YP, Weiss RH. Exogenous attenuation of p21Waf1/Cip1 decreases mesangial cell hypertrophy as a result of hyperglycemia and IGF1. J Am Soc Nephml 2004; 15: 575-584.
44. Masson E, Wiernsperger N, Lagarde M, El Bawab S. Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implications of gangliosides. Biochem J 2005; 388: 537-544.
45. Al-Douahji M, Brugarolas J, Brown PA, Stehman-Breen CO, Alpers CE, Shankland SJ. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney Int 1999; 56: 1691-1699.
46. Wolf G, Shankland SJ. Cell cycle control in glomerular disease. Prog Cell Cycle Res 2003; 5: 71-79.
47. Monkawa T, Hiromura K, Wolf G, Shankland SJ. The hypertrophic effect of transforming growth factor-beta is reduced in the absence of cyclin-dependent kinase-inhibitors p21 and p27. J Am Soc Nephrol 2002; 13: 1172-8117.
48. Kowluru A. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 2003; 52: 818-823.